Dry Powder Inhaler
Dry Powder Inhaler is a medical device with 8 clinical trials. Currently 4 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
4
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
A Study of Mosliciguat in PH-ILD
Pressurized Meter Dose Inhaler V/S Dry Powder Inhaler
A Study of Inhaled AZD8630 in Adolescents With Asthma
Clinical Trials (8)
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
A Study of Mosliciguat in PH-ILD
Pressurized Meter Dose Inhaler V/S Dry Powder Inhaler
A Study of Inhaled AZD8630 in Adolescents With Asthma
A Phase 1 Study of Mosliciguat in Healthy, Adult Males
Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)
Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8